WallStreetZenWallStreetZen

NASDAQ: PRTG
Portage Biotech Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Portage Biotech revenue was $0.00 for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, PRTG annual revenue was $0.0, with N/A growth year-over-year.

PRTG revenue history

Current Revenue
$0.0
Current Earnings
-$67.3M
Current Profit Margin
0%

Be the first to know when PRTG announces revenue.

PRTG Revenue History By Year

PRTG Yearly RevenuePRTG RevenuePRTG ChangePRTG Revenue Growth
2024-03-31$0.00N/AN/A
2023-03-31$0.00N/AN/A
2022-03-31$0.00N/AN/A
2021-03-31$0.00N/AN/A
2020-03-31$0.00N/AN/A
2019-03-31$0.00N/AN/A
2018-03-31$0.00N/AN/A

1 of 1

Portage Biotech Revenue FAQ

What was PRTG's revenue last quarter?

On Invalid Date, Portage Biotech (NASDAQ: PRTG) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Portage Biotech's revenue was $0.00.

What was Portage Biotech's revenue in 2024?

Portage Biotech's annual revenue for the twelve months ending Mar 31, 2024 was $0.00, a N/A decrease year over year.

How much does Portage Biotech make in a day?

Based on Portage Biotech annual revenue for the past five years, PRTG makes an average of $0.00 per day.

What was Portage Biotech's annual revenue growth in the past year?

As of Q2 2025, Portage Biotech's revenue has grown null year over year. Portage Biotech's revenue in the past year totaled $0.00.

How much does Portage Biotech make in a year?

Portage Biotech's revenue by year for the past five years is:
  • Portage Biotech's revenue for the twelve months ending Mar 31, 2024 was $0.00, a N/A decrease year over year.
  • Portage Biotech's annual revenue for Mar 31, 2023 was $0.00, a N/A decrease from 2022.
  • Portage Biotech's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Portage Biotech's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Portage Biotech's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.